September 2019 | San Diego Biotechnology Network

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in China

September 30, 2019 sandiegobiotech Comments Off

LA JOLLA, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the?NASDAQ Global Market?(NASDAQ:MNOV) and the JASDAQ Market of the?Tokyo Stock Exchange?(Code Number: 4875), today announced that it has rec… […]

AnaptysBio Reports Positive Topline Data from Interim Analysis of GALLOP Phase 2 Clinical Trial of ANB019 Monotherapy in Moderate-to-Severe Generalized Pustular Psoriasis

September 30, 2019 sandiegobiotech Comments Off

SAN DIEGO, Sept. 30, 2019 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced positive topli… […]

?We are desperate for new therapies?

September 30, 2019 sandiegobiotech Comments Off

Experts discuss AML during the Sanford Burnham Prebys community lecture series?

Bill Veljovich had never been sick in his life. ?Not even joint pain,? shared the 80-year-old retired engineer at our recent Fleet Science Center discussion about acute my… […]

Skin-Cells-Turned-to-Heart-Cells Help Unravel Genetic Underpinnings of Cardiac Function

September 30, 2019 sandiegobiotech Comments Off

[…]

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

September 30, 2019 sandiegobiotech Comments Off

BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that members of the management team will present at the following investor and industry conferences in October: Cell & Gene Me… […]

Illumina and Broad Institute Announce Agreement to Co-Develop Genomic Secondary Analysis Tools

September 30, 2019 sandiegobiotech Comments Off

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and the Broad Institute of MIT and Harvard today announced they have entered into a collaboration for the co-development of secondary genomic analysis algorithms and software. Top data scientist… […]

AnaptysBio to Present at the Cantor Fitzgerald Global Healthcare Conference

September 28, 2019 sandiegobiotech Comments Off

SAN DIEGO, Sept. 27, 2019 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Sur… […]

Ionis honors its navigating CEO

September 27, 2019 sandiegobiotech Comments Off

As founder and engine of Ionis, Dr. Stanley T. Crooke changed medical history […]

At Venture Summit, 3 Takeaways For Entrepreneurs From VC Phil Black

September 27, 2019 sandiegobiotech Comments Off

No one would argue that San Diego is overflowing with venture capitalists in the way, say, the San Francisco Bay Area is. In fact, the region?s relative dearth of investors is often bemoaned by local entrepreneurs. But, at least once yearly, that chang… […]

Ribometrix Announces $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform

September 27, 2019 sandiegobiotech Comments Off

DURHAM, N.C.–(BUSINESS WIRE)–Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, today announced $7.8 million in additional funding from existing investors, the Dementia Discove… […]